Sales | 148.66M |
Cost of products sold | 130.57M |
Restructuring charges | |
Gross profit | 18.01M |
Operating expenses: | |
Research and development | 1.38M |
Selling, general and administrative | 13.82M |
Restructuring charges | 221K |
Total operating expenses | 15.42M |
Operating income (loss) | 2.59M |
Other income (expense): | |
Interest expense | -112K |
Interest and other income (expense) | |
Total other income (expense) | 39K |
Loss before taxes | |
Taxes | -113K |
Net loss from continuing operations | |
Net loss from discontinued operations | |
Net loss | 2.75M |
Basic net loss per share | |
Loss from continuing operations (in Dollars per share) | |
Loss from discontinued operations (in Dollars per share) | |
(in Dollars per share) | 0.08 |
Diluted net loss per share | |
Loss from continuing operations (in Dollars per share) | |
Loss from discontinued operations (in Dollars per share) | |
(in Dollars per share) | 0.08 |
Basic weighted average common shares outstanding (in Shares) | 34.44M |
Diluted weighted average common shares outstanding (in Shares) | 34.44M |